Coronavirus | Track virus exposure, ICMR advises States

ICMR suggests sero-survey with indigenous kit to decide future course of action.

May 30, 2020 10:29 pm | Updated 11:38 pm IST - NEW DELHI

A blood sample ready to be posted back to the Lab is pictured in a micro sampling collection tube, as a man uses an IgG Antibody Test Kit which identifies Immunoglobulin G antibodies related to SARS-CoV-2, the virus that causes COVID-19, in London on May 28, 2020, during the COVID-19 pandemic. - This type of test confirms if you have previously had the coronavirus as Financial Times research published Thursday, May 28 that Britain has suffered the highest death rate from the coronavirus among the most-affected countries with comparable tracking data. (Photo by JUSTIN TALLIS / AFP)

A blood sample ready to be posted back to the Lab is pictured in a micro sampling collection tube, as a man uses an IgG Antibody Test Kit which identifies Immunoglobulin G antibodies related to SARS-CoV-2, the virus that causes COVID-19, in London on May 28, 2020, during the COVID-19 pandemic. - This type of test confirms if you have previously had the coronavirus as Financial Times research published Thursday, May 28 that Britain has suffered the highest death rate from the coronavirus among the most-affected countries with comparable tracking data. (Photo by JUSTIN TALLIS / AFP)

The Indian Council of Medical Research (ICMR) on Saturday advised the States to conduct sero-surveys to measure the coronavirus exposure in the population using IgG ELISA Test.

As per the direction of the council, the coronavirus(COVID-19 ) exposure in the general population as well as in high-risk populations would be measured and the outcome will help “decide the future course of action against the pandemic”.

ICMR-NIN to take up rapid survey for COVID-19 in twin cities hotspots

“The numbers and frequency in different groups to be tested has been entrusted with the States depending upon the requirement and situation in that particular area,” the note said.

The sero-survey would be conducted using an IgG ELISA kit. Scientists at the ICMR-National Institute of Virology, Pune, have developed and validated an indigenous IgG ELISA test for antibody detection for SARS-CoV-2 .

The test has undergone intense validation in three stages and has been found to have high sensitivity and specificity.

ICMR removes ₹4,500 cap on COVID-19 test | ICMR, Bharat Biotech tie up for Indian COVID-19 vaccine

The ICMR said that it had offered to provide technical support to the States/ Union Territories, if required, in planning and carrying out sero-surveys using IgG Elisa test kits and also interpreting the results.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.